| | 123441-03-2 Basic information More.. |
| Product Name: | Rivastigmine | | Synonyms: | (S)-N-Ethyl-N-Methyl- 3-[1-(diMethylaMino)ethyl]- phenyl carbaMate;S-RivastigMine;CarbaMic acid, N-ethyl-N-Methyl-, 3-[(1S)-1-(diMethylaMino)ethyl]phenyl ester;RivastigiMine;(S)-3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate;Revastigmine;N-Ethyl-N-methylcarbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl-ester;Revastigmine (S)-3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate | | CAS: | 123441-03-2 | | MF: | C14H22N2O2 | | MW: | 250.34 | | EINECS: | 602-936-0 | | Mol File: | 123441-03-2.mol |  |
Use
Rivastigmine (Exelon, EA 713) is apseudoirreversible noncompetitive carbamate inhibitor ofAChE. Although the half-life is approximately 2 hours,the inhibitory properties of this agent last for 10 hours becauseof the slow dissociation of the drug from the enzyme.The Food and Drug Administration (FDA) approved its usein mild-to-moderate Alzheimer disease in April 2000. InJuly 2007, rivastigmine was granted approval for use inmanaging mild-to-moderate dementia associated withParkinson disease.
- Rivastigmine
-
- US $10.00 / KG
- 2025-06-12
- CAS:123441-03-2
- Min. Order: 100KG
- Purity: 99%
- Supply Ability: 100 mt
- Rivastigmine
-
- US $47.00-81.00 / mg
- 2025-06-11
- CAS:123441-03-2
- Min. Order:
- Purity: 99.85%
- Supply Ability: 10g
- Rivastigmine
-
- US $47.00-81.00 / mg
- 2025-06-11
- CAS:123441-03-2
- Min. Order:
- Purity: 99.85%
- Supply Ability: 10g
|
|
123441-03-2
Recommend Suppliers |
|